Evidence map›Paper›PMID 27258850›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2016

A New Ir-NHC Catalyst for Signal Amplification by Reversible Exchange in D2 O.

Peter Spannring, Indrek Reile, Meike Emondts, Philipp P M Schleker, Niels K J Hermkens, Nick G J van der Zwaluw, Bram J A van Weerdenburg, Paul Tinnemans, Marco Tessari, Bernhard Blümich and 2 more

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. High HThe journal of physical chemistry letters · 2025
    Article
  4. The journal of physical chemistry letters · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Metabolic Tumor Imaging with Rapidly Signal-Enhanced 1-Chemphyschem : a European journal of chemical physics and physical chemistry · 2023
    Article
  11. Article
  12. RapidAnalytical chemistry · 2022
    Article
  13. Analysis of Complex Mixtures by Chemosensing NMR UsingAccounts of chemical research · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Reversible Hyperpolarization of Ketoisocaproate Using Sulfoxide-containing Polarization Transfer Catalysts.Chemphyschem : a European journal of chemical physics and physical chemistry · 2021
    Article
  18. Rational ligand choice extends the SABRE substrate scope.Chemical communications (Cambridge, England) · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Peter SpannringInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Indrek ReileInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Meike EmondtsRWTH Aachen, Institut für Technische und Makromolekulare Chemie, Worringerweg 2, 52074 Aachen, Germany.
Philipp P M SchlekerRWTH Aachen, Institut für Technische und Makromolekulare Chemie, Worringerweg 2, 52074 Aachen, Germany.
Niels K J HermkensInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Nick G J van der ZwaluwInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Bram J A van WeerdenburgInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Paul TinnemansInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Marco TessariInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Bernhard BlümichRWTH Aachen, Institut für Technische und Makromolekulare Chemie, Worringerweg 2, 52074 Aachen, Germany.
Floris P J T RutjesInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Martin C FeitersInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands. m.feiters@science.ru.nl.ORCID http://orcid.org/0000-0003-0130-835X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NMR signal amplification by reversible exchange (SABRE) has been observed for pyridine, methyl nicotinate, N-methylnicotinamide, and nicotinamide in D2 O with the new catalyst [Ir(Cl)(IDEG)(COD)] (IDEG=1,3-bis(3,4,5-tris(diethyleneglycol)benzyl)imidazole-2-ylidene). During the activation and hyperpolarization steps, exclusively D2 O was used, resulting in the first fully biocompatible SABRE system. Hyperpolarized (1) H substrate signals were observed at 42.5 MHz upon pressurizing the solution with parahydrogen at close to the Earth's magnetic field, at concentrations yielding barely detectable thermal signals. Moreover, 42-, 26-, 22-, and 9-fold enhancements were observed for nicotinamide, pyridine, methyl nicotinate, and N-methylnicotinamide, respectively, in conventional 300 MHz studies. This research opens up new opportunities in a field in which SABRE has hitherto primarily been conducted in CD3 OD. This system uses simple hardware, leaves the substrate unaltered, and shows that SABRE is potentially suitable for clinical purposes.

Indexed as

Biocompatible MaterialsCatalysisCoordination ComplexesCrystallography, X-RayDeuterium OxideIridiumMagnetic Resonance SpectroscopyMolecular ConformationNiacinamideWaterBiocompatible MaterialsCoordination ComplexesDeuterium OxideIridiumNiacinamideN-methylnicotinamideWaterbiocompatiblecarbenesligand designparahydrogenSABREwater-soluble

Identifiers

PMID27258850
PMCPMC5089654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.